An HIV vaccine candidate developed at the Duke Human Vaccine Institute has demonstrated the ability to trigger low levels of a rare type of neutralising antibodies (bnAbs) in a small group of participants.
After receiving a cord blood stem cell transplant to treat acute myeloid leukaemia a woman with diagnosed HIV has had no detectable levels of HIV for 14 months
Acknowledging pleasure as a key driver of sexual behaviour has more success in teaching safe sex than traditional sex education – as well as targeting STI/HIV risk reduction.
Dr Glass, Director of the Fogarty International Center, and Director at the NIH, explores the relationship between NIH and the health research community
A new study estimates HIV disproportionately affects trans feminine women, with 20% of trans feminine individuals being positive with the virus, highlighting the need for prevention efforts and appropriate sex education.
A new study on HIV medication treatment discovered persistent disparities between sex and age, potentially subjecting women to worse HIV treatment outcomes on the drug dolutegravir.
A new study focuses on HIV data in sub-Saharan Africa, analysing the number of people living with HIV in 47 countries, the population distribution, and the locations of healthcare facilities.
A new study, published in AIDS and Behavior, finds that healthcare providers still have some social bias about who should be given PrEP - the HIV prevention drug.
With 7.5 million people living with HIV, how has climate change and COVID-19 affected the South African governments control over the AIDS crisis and which demographics have been hit the hardest?
Research by the American Heart Association found that people with HIV are more likely to experience heart attacks - with "higher rates of sudden cardiac death".
The REACH study found that 97% of women and girls in Uganda, South Africa and Zimbabwe are happy to work with HIV prevention methods - globally, half of all people living with HIV are women.
The team will have results to discuss in April, 2022 - they nurse the hope that this HIV vaccine could stop different geographical strains, after 40 years of no cure.
